InvestorsHub Logo
Followers 22
Posts 888
Boards Moderated 0
Alias Born 05/09/2012

Re: Hungry_Ghost post# 380277

Wednesday, 10/27/2021 2:38:11 PM

Wednesday, October 27, 2021 2:38:11 PM

Post# of 403217
So, how would IPIX pivot to a Phase 2/3 registration enabling trial as a broad spectrum anti-viral for multiple classes of moderate to severe virus cases (influenza, coronavirus, enveloped, non-enveloped etc) requiring hospitalization?

Would we need to design a Phase 3 for each separate class of virus separately or would there be a way to combine a number of them together? Thoughts? I'd think this is where a deep pocketed partner would come into play as they could surely see the massive potential for success and $$$
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News